SEC Tracker
Get the app

Tango Therapeutics TNGX

On the Closing Date, New Tango, BCTG Holdings, LLC, a Delaware limited liability company

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.2
Material contract
Exhibit 10.4
Material contract
Exhibit 10.5
Material contract
Exhibit 10.6
Material contract
Exhibit 10.7
Material contract
Exhibit 10.8
Material contract
Exhibit 10.9
Material contract
Exhibit 10.10
Material contract
Exhibit 10.11
Material contract
Exhibit 99.1
Press release
  • Completes an acquisition or sale of assets (2.01)
  • Changes shareholder rights (3.03)
  • Changes its auditor (4.01)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Amends its charter or bylaws (5.03)
  • Changes its ethics code (5.05)
  • Changes its shell company status (5.06)
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Tango Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Elite Pharmaceuticals ELTP public float $534M, Sep 30, 2025
  2. Iovance Biotherapeutics IOVA public float $535M, Jun 30, 2025
  3. Opko Health OPK public float $540M, Dec 31, 2025
  4. Savara SVRA public float $544M, Jun 30, 2025
  5. Xencor XNCR public float $556M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.